China announces on-line drug crackdown

20 April 2008

China's State Food and Drug Administration has given details of a crackdown against the illegal sale of prescription drugs on-line, according to a report by the Xinhua news agency. Confirming a previous report that fake web sites are being used, the SFDA's spokesman told reporters that these are often disguised as real hospitals or medical institutions.

Last year, one counterfeit gang even set up a fake SFDA web site with a listing of allegedly authorized medicines, some of which were bogus. Users of the site were redirected to a portal where counterfeit drugs could be purchased (Marketletters passim).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight